September 3, 2019 / 5:06 AM / 15 days ago

BRIEF-Kuros Biosciences Announces U.S. FDA Approval Of IND Application

Sept 3 (Reuters) - Kuros Biosciences AG:

* ANNOUNCES U.S. FDA APPROVAL OF IND APPLICATION TO INITIATE FIBRIN-PTH PHASE 2A CLINICAL TRIAL IN SPINAL FUSION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below